News Copaxone first on FDA's list for faster complex generic appr... Teva will attempt to block generic launch in courts
Views & Analysis Neurotechnology for tailored patient care Advanced implantable medical devices could treat hundreds of chronic conditions in the future.
News FDA names MDMA a 'breakthrough' for post-traumatic stress US non-profit organisation to begin late-stage trials this year
News AZ to develop Parkinson's drug with Takeda AstraZeneca could receive up to $400 million from Takeda after approaching the company to jointly develop and market a new treatment for Parkinson’s disease (PD).
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.